- Home
- RGNX vs VHI Comparison
RGNX vs VHI Comparison
Compare RGNX & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- VHI
- Stock Information
- Founded
- RGNX 2008
- VHI 1932
- Country
- RGNX United States
- VHI United States
- Employees
- RGNX N/A
- VHI N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- VHI Major Chemicals
- Sector
- RGNX Health Care
- VHI Industrials
- Exchange
- RGNX Nasdaq
- VHI Nasdaq
- Market Cap
- RGNX 451.1M
- VHI 454.3M
- IPO Year
- RGNX 2015
- VHI N/A
- Fundamental
- Price
- RGNX $9.03
- VHI $16.16
- Analyst Decision
- RGNX Strong Buy
- VHI Sell
- Analyst Count
- RGNX 8
- VHI 1
- Target Price
- RGNX $28.50
- VHI $12.00
- AVG Volume (30 Days)
- RGNX 502.6K
- VHI 10.3K
- Earning Date
- RGNX 11-05-2025
- VHI 11-06-2025
- Dividend Yield
- RGNX N/A
- VHI 1.97%
- EPS Growth
- RGNX N/A
- VHI 269.89
- EPS
- RGNX N/A
- VHI 3.44
- Revenue
- RGNX $155,782,000.00
- VHI $2,093,500,000.00
- Revenue This Year
- RGNX $203.27
- VHI $22.20
- Revenue Next Year
- RGNX $0.58
- VHI $7.66
- P/E Ratio
- RGNX N/A
- VHI $4.72
- Revenue Growth
- RGNX 74.95
- VHI 4.04
- 52 Week Low
- RGNX $5.04
- VHI $14.10
- 52 Week High
- RGNX $13.48
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- RGNX 49.37
- VHI 47.39
- Support Level
- RGNX $8.82
- VHI $15.71
- Resistance Level
- RGNX $10.08
- VHI $16.96
- Average True Range (ATR)
- RGNX 0.54
- VHI 0.56
- MACD
- RGNX -0.05
- VHI -0.00
- Stochastic Oscillator
- RGNX 25.27
- VHI 42.55
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.